| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5K | -50.0% |
| R&D Expense | $1.4M | +276.5% |
| SG&A Expense | $2.9M | -35.7% |
| Operating Income | -$4.2M | +12.2% |
| Income Tax | $0 | — |
| Net Income | -$4.2M | +10.8% |
| EPS (Basic) | -$2.20 | +24.7% |
| EPS (Diluted) | -$2.20 | +24.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | +26.9% |
| Accounts Receivable | $3K | -40.0% |
| Current Assets | $2.0M | -27.8% |
| Total Assets | $3.0M | +7.7% |
| Current Liabilities | $813K | +17.5% |
| Total Liabilities | $813K | +17.5% |
| Stockholders' Equity | $2.2M | +4.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.9M | +42.3% |
| Capital Expenditures | $98K | — |
| Investing Cash Flow | -$98K | — |
| Financing Cash Flow | $3.3M | — |
| Free Cash Flow | -$3.0M | +40.3% |